A331920 Stock Overview
Celemics, Inc. designs, manufactures, and distributes sequencing kits.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Celemics, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,730.00 |
| 52 Week High | ₩5,800.00 |
| 52 Week Low | ₩2,745.00 |
| Beta | 0.88 |
| 1 Month Change | -3.87% |
| 3 Month Change | -12.85% |
| 1 Year Change | -27.43% |
| 3 Year Change | -82.20% |
| 5 Year Change | n/a |
| Change since IPO | -85.54% |
Recent News & Updates
Here's Why We're Not Too Worried About Celemics' (KOSDAQ:331920) Cash Burn Situation
Mar 28
What You Need To Know About Celemics, Inc.'s (KOSDAQ:331920) Investor Composition
Dec 17Shareholder Returns
| A331920 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -1.3% | -3.7% | -4.3% |
| 1Y | -27.4% | -1.3% | -1.0% |
Return vs Industry: A331920 underperformed the KR Life Sciences industry which returned -1.3% over the past year.
Return vs Market: A331920 underperformed the KR Market which returned -1% over the past year.
Price Volatility
| A331920 volatility | |
|---|---|
| A331920 Average Weekly Movement | 7.5% |
| Life Sciences Industry Average Movement | 7.5% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A331920's share price has been volatile over the past 3 months.
Volatility Over Time: A331920's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | n/a | Young-hoon Lee | www.celemics.com |
Celemics, Inc. designs, manufactures, and distributes sequencing kits. The company offers BRCA, somatic mutation cancer, and hereditary cancer kits; and NGS Library preparation kits. It also provides customized target enrichment kit, next generation sequencing, NGS unit, and NGS-lab building consulting services.
Celemics, Inc. Fundamentals Summary
| A331920 fundamental statistics | |
|---|---|
| Market cap | ₩30.45b |
| Earnings (TTM) | -₩3.88b |
| Revenue (TTM) | ₩6.58b |
4.6x
P/S Ratio-7.9x
P/E RatioIs A331920 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A331920 income statement (TTM) | |
|---|---|
| Revenue | ₩6.58b |
| Cost of Revenue | ₩5.06b |
| Gross Profit | ₩1.52b |
| Other Expenses | ₩5.40b |
| Earnings | -₩3.88b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -474.72 |
| Gross Margin | 23.15% |
| Net Profit Margin | -58.92% |
| Debt/Equity Ratio | 0% |
How did A331920 perform over the long term?
See historical performance and comparison